Sykehusinnkjøp HF has been given the assignment, on behalf of the four regional health companies in Norway, of procuring particle therapy for Norwegian patients that fulfil the indication for such treatment. There is currently no treatment offer within particle therapy in Norway, and thus there is a need to enter into contracts with foreign centre/clinics that can offer this treatment to Norwegian patients. The aim is to enter into a parallel framework agreements with several tenderers. The procurement is divided into two sub-contracts. A) Proton therapy and B) Carbon Ion therapy. Tenderers can submit a tender for both sub-contracts, or for one of the sub-contracts. The contracting authority reserves the right to conduct a dialogue or negotiations with the tenderers in the contest. See the tender documentation, points 1.3 and 4.4 for further information. The service must be provided abroad. Click here https://permalink.mercell.com/168903465.aspx.
Frist
Fristen for mottak av tilbud var 2022-03-11.
Anskaffelsen ble publisert 2022-02-07.
Leverandører
Følgende leverandører er nevnt i tildelingsbeslutninger eller andre anskaffelsesdokumenter:
Kunngjøring av konkurranse (2022-02-07) Gjenstand Anskaffelsens omfang
Tittel: Miscellaneous health services
Referansenummer: 2021/1963
Kort beskrivelse:
Sykehusinnkjøp HF has been given the assignment, on behalf of the four regional health companies in Norway, of procuring particle therapy for Norwegian patients that fulfil the indication for such treatment. There is currently no treatment offer within particle therapy in Norway, and thus there is a need to enter into contracts with foreign centre/clinics that can offer this treatment to Norwegian patients.
The aim is to enter into a parallel framework agreements with several tenderers.
The procurement is divided into two sub-contracts. A) Proton therapy and B) Carbon Ion therapy. Tenderers can submit a tender for both sub-contracts, or for one of the sub-contracts. The contracting authority reserves the right to conduct a dialogue or negotiations with the tenderers in the contest. See the tender documentation, points 1.3 and 4.4 for further information.
The service must be provided abroad.
Click here https://permalink.mercell.com/168903465.aspx.
Sykehusinnkjøp HF has been given the assignment, on behalf of the four regional health companies in Norway, of procuring particle therapy for Norwegian patients that fulfil the indication for such treatment. There is currently no treatment offer within particle therapy in Norway, and thus there is a need to enter into contracts with foreign centre/clinics that can offer this treatment to Norwegian patients.
The aim is to enter into a parallel framework agreements with several tenderers.
The procurement is divided into two sub-contracts. A) Proton therapy and B) Carbon Ion therapy. Tenderers can submit a tender for both sub-contracts, or for one of the sub-contracts. The contracting authority reserves the right to conduct a dialogue or negotiations with the tenderers in the contest. See the tender documentation, points 1.3 and 4.4 for further information.
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Tjenester
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS)
Felles innkjøpsordliste (CPV)
Kode: Diverse helsetjenester📦
Tilleggs-CPV: Tjenesteytelser innen helsevesenet📦 Utførelsessted
NUTS-region: Norge
🏙️
Prosedyre
Prosedyretype: Konkurranse med forhandling
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Ikke aktuelt
Sub-contract A - proton therapy: The estimated annual value for the years 2022-2024 is NOK 36 million to NOK 55 million. Two national centres for particle therapy are being constructed, and are estimated to be operative during 2024. Therefore the need to procure proton therapy from abroad will be gradually reduced in the years 2024-2027. The maximum value is NOK 480 million. The maximum value is based on a 6-year contract period.
Sub-contract B - Carbon Ion therapy: The estimated annual amount is NOK 6 million. The maximum value is NOK 90 million. The maximum value is based on a 6-year contract period.
The framework agreement will be valid for two years, with an option to extend for a further four years.
Sub-contract A - proton therapy: The estimated annual value for the years 2022-2024 is NOK 36 million to NOK 55 million. Two national centres for particle therapy are being constructed, and are estimated to be operative during 2024. Therefore the need to procure proton therapy from abroad will be gradually reduced in the years 2024-2027. The maximum value is NOK 480 million. The maximum value is based on a 6-year contract period.
Sub-contract B - Carbon Ion therapy: The estimated annual amount is NOK 6 million. The maximum value is NOK 90 million. The maximum value is based on a 6-year contract period.
The framework agreement will be valid for two years, with an option to extend for a further four years.
Gjenstand Anskaffelsens omfang
Kort beskrivelse:
Sykehusinnkjøp HF has been given the assignment, on behalf of the four regional health companies in Norway, of procuring particle therapy for Norwegian patients that fulfil the indication for such treatment. There is currently no treatment offer within particle therapy in Norway, and thus there is a need to enter into contracts with foreign centre/clinics that can offer this treatment to Norwegian patients.
Sykehusinnkjøp HF has been given the assignment, on behalf of the four regional health companies in Norway, of procuring particle therapy for Norwegian patients that fulfil the indication for such treatment. There is currently no treatment offer within particle therapy in Norway, and thus there is a need to enter into contracts with foreign centre/clinics that can offer this treatment to Norwegian patients.
The aim is to enter into a parallel framework agreements with several tenderers.
The procurement is divided into two sub-contracts. A) Proton therapy and B) Carbon Ion therapy. Tenderers can submit a tender for both sub-contracts, or for one of the sub-contracts. The contracting authority reserves the right to conduct a dialogue or negotiations with the tenderers in the contest. See the tender documentation, points 1.3 and 4.4 for further information.
The procurement is divided into two sub-contracts. A) Proton therapy and B) Carbon Ion therapy. Tenderers can submit a tender for both sub-contracts, or for one of the sub-contracts. The contracting authority reserves the right to conduct a dialogue or negotiations with the tenderers in the contest. See the tender documentation, points 1.3 and 4.4 for further information.
Tittel på delkontrakt: A. Proton therapy
Delkontraktnummer: 1
Kort beskrivelse:
Including:
Proton therapy for pediatric tumours, including anesthesia when needed, and proton therapy for adult tumours
Varighet: 24 måneder
Tittel på delkontrakt: B. Carbon Ion therapy
Delkontraktnummer: 2
Kort beskrivelse: Carbon Ion therapy for adult tumours.
Juridisk, økonomisk, finansiell og teknisk informasjon Vilkår for deltakelse
Liste og kort beskrivelse av regler og kriterier:
The Tenderer shall operate within proper professional conduct. Technical and professional qualifications are required. See the ‘Invitation to Tender’ for more information, including the documentation requirements.
Prosedyre
Rettslig grunnlag: 32014L0024
Tidspunkt for mottak av tilbud: 10:00
Språk som tilbud eller forespørsler om deltakelse kan sendes inn på: dansk 🗣️
engelsk 🗣️ + 2 til
norsk 🗣️
svensk 🗣️
Oppdragsgiver Identitet
Nasjonalt registreringsnummer: 916879067
Kontakt
Kontaktpunkt: Postmottak Sykehusinnkjøp
Adresse til kjøperprofilen: http://www.sykehusinnkjop.no/🌏
Referanse Tilleggsinformasjon
Sub-contract A - proton therapy: The estimated annual value for the years 2022-2024 is NOK 36 million to NOK 55 million. Two national centres for particle therapy are being constructed, and are estimated to be operative during 2024. Therefore the need to procure proton therapy from abroad will be gradually reduced in the years 2024-2027. The maximum value is NOK 480 million. The maximum value is based on a 6-year contract period.
Sub-contract A - proton therapy: The estimated annual value for the years 2022-2024 is NOK 36 million to NOK 55 million. Two national centres for particle therapy are being constructed, and are estimated to be operative during 2024. Therefore the need to procure proton therapy from abroad will be gradually reduced in the years 2024-2027. The maximum value is NOK 480 million. The maximum value is based on a 6-year contract period.
Sub-contract B - Carbon Ion therapy: The estimated annual amount is NOK 6 million. The maximum value is NOK 90 million. The maximum value is based on a 6-year contract period.
The framework agreement will be valid for two years, with an option to extend for a further four years.
Utfyllende informasjon Klageinstans
Navn: Indre og Østre Finnmark Tingrett
Poststed: Vadsø
Land: Norge 🇳🇴
Kilde: OJS 2022/S 030-078296 (2022-02-07)
Kunngjøring om tildeling av kontrakt (2022-06-29) Gjenstand Anskaffelsens omfang
Kort beskrivelse:
Sykehusinnkjøp HF has been given the assignment, on behalf of the four regional health companies in Norway, of procuring particle therapy for Norwegian patients that fulfil the indication for such treatment. There is currently no treatment offer within particle therapy in Norway, and thus there is a need to enter into contracts with foreign centre/clinics that can offer this treatment to Norwegian patients.
Click here: https://permalink.mercell.com/182209705.aspx
Sykehusinnkjøp HF has been given the assignment, on behalf of the four regional health companies in Norway, of procuring particle therapy for Norwegian patients that fulfil the indication for such treatment. There is currently no treatment offer within particle therapy in Norway, and thus there is a need to enter into contracts with foreign centre/clinics that can offer this treatment to Norwegian patients.
Lot A - proton therapy: The estimated annual value for the years 2022-2024 is NOK 36 million to NOK 55 million. Two national centres for particle therapy are being constructed, and are estimated to be operative during 2024. Therefore the need to procure proton therapy from abroad will be gradually reduced in the years 2024-2027. The maximum value over a 6-year period is NOK 480 million. The total value stated per lot is calculated per year for all four providers.
Lot B - Carbon Ion therapy: The estimated annual amount is NOK 6 million. The maximum value over a 6-year period is NOK 90 million. The value stated per lot is calculated per year for both providers.
Lot A - proton therapy: The estimated annual value for the years 2022-2024 is NOK 36 million to NOK 55 million. Two national centres for particle therapy are being constructed, and are estimated to be operative during 2024. Therefore the need to procure proton therapy from abroad will be gradually reduced in the years 2024-2027. The maximum value over a 6-year period is NOK 480 million. The total value stated per lot is calculated per year for all four providers.
Lot B - Carbon Ion therapy: The estimated annual amount is NOK 6 million. The maximum value over a 6-year period is NOK 90 million. The value stated per lot is calculated per year for both providers.
Tildeling av kontrakt
Dato for kontraktinngåelse: 2022-06-24 📅
Navn: Kommunalförbundet Avancerad Strålbehandling
Postadresse: Box 6374
Poststed: Uppsala
Postnummer: 75136
Land: Sverige 🇸🇪
Totalverdi for anskaffelsen: 55 000 000 NOK 💰
Navn: Universitätsklinikum Heidelberg
Postadresse: Im Neuenheimer Feld 672
Poststed: Heidelberg
Postnummer: 69120
Land: Tyskland 🇩🇪
Navn: Dansk Center for Partikelterapi, Region Midtjylland
Postadresse: Palle Juuls Boulevard 75
Poststed: Aarhus N
Postnummer: 8200
Land: Danmark 🇩🇰
Navn: Westdeutsches Protonentherapiezentrum Essen (WPE) gGmbH
Postadresse: Hufelandstr. 55
Poststed: Essen
Postnummer: 45147
Totalverdi for anskaffelsen: 6 000 000 NOK 💰
Navn: Fondazione cnao
Postadresse: STRADA CAMPEGGI 53
Poststed: Pavia
Postnummer: 27100
Land: Italia 🇮🇹 Informasjon om tilbud
Antall mottatte tilbud: 5
2
Referanse Tilleggsinformasjon
Lot A - proton therapy: The estimated annual value for the years 2022-2024 is NOK 36 million to NOK 55 million. Two national centres for particle therapy are being constructed, and are estimated to be operative during 2024. Therefore the need to procure proton therapy from abroad will be gradually reduced in the years 2024-2027. The maximum value over a 6-year period is NOK 480 million. The total value stated per lot is calculated per year for all four providers.
Lot A - proton therapy: The estimated annual value for the years 2022-2024 is NOK 36 million to NOK 55 million. Two national centres for particle therapy are being constructed, and are estimated to be operative during 2024. Therefore the need to procure proton therapy from abroad will be gradually reduced in the years 2024-2027. The maximum value over a 6-year period is NOK 480 million. The total value stated per lot is calculated per year for all four providers.
Lot B - Carbon Ion therapy: The estimated annual amount is NOK 6 million. The maximum value over a 6-year period is NOK 90 million. The value stated per lot is calculated per year for both providers.